These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1057 related articles for article (PubMed ID: 6352996)
1. [Immunohistological evaluation of melanoma using anti-human melanoma monoclonal antibody]. Kageshita T; Jono M; Ono T; Arao T; Imai K Nihon Hifuka Gakkai Zasshi; 1983 Apr; 93(5):537-40. PubMed ID: 6352996 [No Abstract] [Full Text] [Related]
2. Human IgM monoclonal anti-GD2 antibody: reactivity to a human melanoma xenograft. Katano M; Saxton RE; Tsuchida T; Irie RF Jpn J Cancer Res; 1986 Jun; 77(6):584-94. PubMed ID: 3089993 [TBL] [Abstract][Full Text] [Related]
3. [Current status of monoclonal antibodies to human melanoma and its application]. Imai K; Adachi M; Yachi A Gan To Kagaku Ryoho; 1983 Mar; 10(3):852-60. PubMed ID: 6192770 [TBL] [Abstract][Full Text] [Related]
4. [Immunohistological detection of monoclonal antibodies to histocompatibility antigens in melanoma cells and nevus cells]. Kageshita T; Nagano H; Johno M; Ono T; Arao T; Imai K Nihon Hifuka Gakkai Zasshi; 1984 Oct; 94(11):1285-9. PubMed ID: 6521021 [No Abstract] [Full Text] [Related]
5. [Monoclonal antitumor antibodies--its application to diagnosis and treatment of tumors]. Taniguchi M; Wakabayashi S Gan No Rinsho; 1983 May; 29(6):654-8. PubMed ID: 6876435 [TBL] [Abstract][Full Text] [Related]
6. [Clinical application of monoclonal antibodies to human malignant melanoma-associated antigens]. Kageshita T; Ishihara K Gan To Kagaku Ryoho; 1985 Sep; 12(9):1744-8. PubMed ID: 3899015 [TBL] [Abstract][Full Text] [Related]
7. Characterization of monoclonal antibody 155.8 and partial characterization of its proteoglycan antigen on human melanoma cells. Harper JR; Bumol TF; Reisfeld RA J Immunol; 1984 Apr; 132(4):2096-104. PubMed ID: 6199423 [TBL] [Abstract][Full Text] [Related]
8. The idiotype (Id) cascade in mice elicited the production of anti-R24 Id and anti-anti-Id monoclonal antibodies with antitumor and protective activity against human melanoma. Ramos AS; Parise CB; Travassos LR; Han SW; de Campos-Lima PO; de Moraes JZ Cancer Sci; 2011 Jan; 102(1):64-70. PubMed ID: 21070480 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Mittelman A; Chen ZJ; Liu CC; Hirai S; Ferrone S Cancer Res; 1994 Jan; 54(2):415-21. PubMed ID: 8275478 [TBL] [Abstract][Full Text] [Related]
10. In vitro complex formation and biodistribution of mouse antitumor monoclonal antibody in cancer patients. Sakahara H; Reynolds JC; Carrasquillo JA; Lora ME; Maloney PJ; Lotze MT; Larson SM; Neumann RD J Nucl Med; 1989 Aug; 30(8):1311-7. PubMed ID: 2754487 [TBL] [Abstract][Full Text] [Related]
11. Analysis of anti-tumor antibodies in mice and rabbits induced by monoclonal anti-idiotope antibodies. Chattopadhyay P; Starkey J; Raychaudhuri S J Immunol; 1991 Sep; 147(6):2055-62. PubMed ID: 1890311 [TBL] [Abstract][Full Text] [Related]
12. Syngeneic monoclonal anti-melanoma antibody that inhibits experimental lung metastasis of B16 melanoma. Gunji Y; Taniguchi M Jpn J Cancer Res; 1986 Jun; 77(6):595-601. PubMed ID: 3089994 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a proapoptotic antiganglioside GM2 monoclonal antibody and evaluation of its therapeutic effect on melanoma and small cell lung carcinoma xenografts. Retter MW; Johnson JC; Peckham DW; Bannink JE; Bangur CS; Dresser K; Cai F; Foy TM; Fanger NA; Fanger GR; Woda B; Rock KL Cancer Res; 2005 Jul; 65(14):6425-34. PubMed ID: 16024647 [TBL] [Abstract][Full Text] [Related]
14. Syngeneic antiidiotypic antisera to murine antihuman high-molecular-weight melanoma-associated antigen monoclonal antibodies. Kusama M; Kageshita T; Tsujisaki M; Perosa F; Ferrone S Cancer Res; 1987 Aug; 47(16):4312-7. PubMed ID: 3607764 [TBL] [Abstract][Full Text] [Related]
15. Mouse monoclonal antibody to a melanoma-carcinoma-associated antigen synthesized by a human melanoma cell line propagated in serum-free medium. Chee DO; Yonemoto RH; Leong SP; Richards GF; Smith VR; Klotz JL; Goto RM; Gascon RL; Drushella MM Cancer Res; 1982 Aug; 42(8):3142-7. PubMed ID: 7046918 [TBL] [Abstract][Full Text] [Related]
16. Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma. Kirkwood JM; Mascari RA; Edington HD; Rabkin MS; Day RS; Whiteside TL; Vlock DR; Shipe-Spotloe JM Cancer; 2000 Jun; 88(12):2693-702. PubMed ID: 10870051 [TBL] [Abstract][Full Text] [Related]
17. Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant. McCaffery M; Yao TJ; Williams L; Livingston PO; Houghton AN; Chapman PB Clin Cancer Res; 1996 Apr; 2(4):679-86. PubMed ID: 9816218 [TBL] [Abstract][Full Text] [Related]
18. Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a phase II trial. Oratz R; Speyer JL; Wernz JC; Hochster H; Meyers M; Mischak R; Spitler LE J Biol Response Mod; 1990 Aug; 9(4):345-54. PubMed ID: 2395000 [TBL] [Abstract][Full Text] [Related]
19. Development and characterization of a mouse monoclonal antibody, MoAb HMSA-1, against a melanosomal fraction of human malignant melanoma. Akutsu Y; Jimbow K Cancer Res; 1986 Jun; 46(6):2904-11. PubMed ID: 3516387 [TBL] [Abstract][Full Text] [Related]
20. Immunofluorescence imaging as a tool for studying the pharmacokinetics of a human monoclonal single chain fragment antibody. Ramjiawan B; Ariano RE; Mantsch HH; Maiti P; Jackson M IEEE Trans Med Imaging; 2002 Oct; 21(10):1317-23. PubMed ID: 12585714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]